And After the Test
19th October 2020
Excerpt from article:
Two genetic counselors call for an increased focus on post-test patient care, in an editorial appearing at BMJ Opinion.
Christine Patch and Anna Middleton, both from the Connecting Science program at the Wellcome Genome Campus, write that though genomic testing is increasingly part of mainstream healthcare, its main effect in the coming years will likely mostly be in the diagnosis of rare diseases. In particular, they write that genetic testing will shorten the diagnostic odyssey that many patients with a suspected rare genetic disease go through.